- June 7, 2016
- Posted by: emobile
- Category: Researcher's Corner
Emobileclinic Researchers’ corner
The Scientists from the University of Zurich have uncovered why several cancer cells adapt relatively quickly to the treatment with therapeutic antibodies in invasive forms of breast cancer; rather than dying off, they are merely rendered inactive. The researchers have now developed an active substance that kills the cancer cells very effectively without harming healthy cells .This is contained in the Journal of Nature Communication published on June 3rd, 2016.